EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $572 | -100.0% | 29,906 | -59.4% | 0.07% | -36.8% |
| Q3 2022 | $1,154,000 | +72.0% | 73,610 | +128.3% | 0.11% | +50.0% |
| Q2 2022 | $671,000 | +169.5% | 32,240 | +136.8% | 0.08% | +171.4% |
| Q4 2021 | $249,000 | +12.2% | 13,614 | +12.0% | 0.03% | +27.3% |
| Q2 2021 | $222,000 | -63.2% | 12,159 | -54.5% | 0.02% | -67.6% |
| Q1 2021 | $604,000 | +85.8% | 26,735 | +45.5% | 0.07% | +19.3% |
| Q3 2019 | $325,000 | -14.5% | 18,378 | -4.9% | 0.06% | -13.6% |
| Q4 2018 | $380,000 | +71.2% | 19,327 | +54.6% | 0.07% | +112.9% |
| Q3 2018 | $222,000 | -5.9% | 12,501 | +15.0% | 0.03% | -43.6% |
| Q1 2017 | $236,000 | +8.3% | 10,871 | -36.1% | 0.06% | -5.2% |
| Q3 2016 | $218,000 | – | 17,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |